These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22642788)

  • 1. Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study.
    Close H; Mason JM; Wilson D; Hungin AP
    BMC Gastroenterol; 2012 May; 12():56. PubMed ID: 22642788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
    Toghanian S; Johnson DA; Stålhammar NO; Zerbib F
    Clin Drug Investig; 2011 Oct; 31(10):703-15. PubMed ID: 21756007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.
    Benson VS; Müllerová H; Vestbo J; Wedzicha JA; Patel A; Hurst JR;
    Respir Med; 2015 Sep; 109(9):1147-54. PubMed ID: 26166017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
    Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
    Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle.
    Heading RC
    Clin Med (Lond); 2017 Apr; 17(2):132-136. PubMed ID: 28365622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastro-oesophageal reflux disease (GORD) in Australian general practice patients.
    Miller G; Wong C; Pollack A
    Aust Fam Physician; 2015 Oct; 44(10):701-4. PubMed ID: 26484482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes.
    Quinlivan A; Neuen D; Hansen D; Stevens W; Ross L; Ferdowsi N; Proudman SM; Walker JG; Sahhar J; Ngian GS; Apostolopoulos D; Host LV; Major G; Basnayake C; Morrisroe K; Nikpour M
    Arthritis Res Ther; 2024 Jun; 26(1):124. PubMed ID: 38918847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.
    Bell JC; Schneuer FJ; Harrison C; Trevena L; Hiscock H; Elshaug AG; Nassar N
    Arch Dis Child; 2018 Jul; 103(7):660-664. PubMed ID: 29472195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.
    Chang AB; Lasserson TJ; Gaffney J; Connor FL; Garske LA
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD004823. PubMed ID: 21249664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?
    Menon S; Nightingale P; Trudgill N
    United European Gastroenterol J; 2014 Oct; 2(5):374-82. PubMed ID: 25360315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.